Literature DB >> 14725262

Invasive Mycobacterium marinum infections.

Timothy Lahey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14725262      PMCID: PMC3035536          DOI: 10.3201/eid0911.030192

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Mycobacterium marinum infections, commonly known as fish tank granuloma, produce nodular or ulcerating skin lesions on the extremities of healthy hosts. Delay of diagnosis is common, and invasion into deeper structures such as synovia, bursae, and bone occurs in approximately one third of reported case-patients (). A 49-year-old man with diabetes, who had received kidney transplant from a living relative 8 years previously, sought treatment after 5 months of worsening swelling and tenderness of the left elbow. Of note, he had injured his left ring finger while cleaning barnacles from a piling 5 years previously and had contracted a secondary infection that never completely healed despite three courses of antimicrobial drugs and surgical debridement. Physical examination showed marked swelling, tenderness, and warmth of the left elbow, as well as of the left ring finger, which was erythematous. Sterile aspiration of the olecranon bursa showed 7,500 leukocytes (62% lymphocytes) and 141,000 erythrocytes. Results of Gram stain and routine cultures were negative. Magnetic resonance imaging of the left arm showed soft tissue edema of the olecranon bursa and the left fourth flexor digitorum longus tendon, and no osteomyelitis. Three weeks later, olecranon bursa aspirate fluid cultures incubated on chocolate agar and 7H11 plates at 31°C, as well as on algae slant, and mycobacterial growth indicator tubes incubated at 37°C grew M.ycobacterium marinum. The isolate was susceptible to most agents but showed intermediate susceptiblity to ciprofloxacin (MIC 2 μg/mL) and was resistant to ampicillin/clavulanate and erythromycin (MIC 8 μg/mL and 32 μg/mL, respectively). A treatment regimen of rifampin and ethambutol was begun, and the patient showed a dramatic improvement in the ensuing several weeks. The patient has completed 9 of 11.4 planned months of therapy and continues to do well, with frequent office visits. Case reports from English language MEDLINE articles since 1966 under the subject heading Mycobacterium marinum were cross-referenced with articles containing the following text words: disseminated, osteomyelitis, arthritis, synovitis, and bursitis. Ten case reports were identified, and a hand search through pertinent articles’ references yielded 13 additional reports. A total of 35 cases of invasive M. marinum disease were then reviewed, according to patient age and sex, symptoms, source of infection, immune impairment, time to diagnosis, and type as well as duration of therapy (–) (Table).
Table

Summary of Invasive Mycobacterium marinum infection cases published since 1966

Ref.AgeSexSymptomsSourceImmune impairmentDx delay (mo)MedicationsSurgery ?Treatment duration (mo)
(2)32MDisseminated cutaneous, larynxMinor traumaSystemic steroids240I, SYes>36
(3)37MR middle finger osteomyelitisFishing injuryLocal steroid injection3Erythromycin, SYes5
(3)30MR long finger osteomyelitisMinor traumaNone12DeclinedNo--
(3)56MR ring finger tenosynovitisMinor trauma, fishing and cleaning boatsLocal steroid injection1.2EYes9
(3)52ML index finger osteomyelitis and synovitisNoneLocal steroid injection7Cycloserine, ethionamide, RYes?
(3)60MR ring finger synovitis and osteomyelitisShrimp cleaning injuryNone7E, RYes6
(3)55ML long finger synovitis and skin ulcerShrimp cleaning injuryNone23EYes6
(4)30MDisseminated skin nodules, lymphangitisAquarium cleaningSystemic steroids and azathioprine for renal transplant2E, R, TNo?
(5)1.3FDisseminated cutaneous nodulesAquarium exposureNone2E, I, RNo8
(6)26MR hand tenosynovitisFishermanLocal steroid injection8E, P, R, tetracyclineYes?
(6)45MR index tenosynovitisSaltwater fishingLocal steroid injection1E, R, tetracyclineYes?
(6)22MR hand tenosynovitisFishermanNone2I, R, SYes?
(6)56FL hand tenosynovitisFishing injuryLocal steroid injections5I, R, SYes?
(6)53MR hand and forearm synovitis, bursitisFishermanLocal steroid injections78E, I, R, SYes?
(7)47FR hand tenosynovitis and osteomyelitisNoneNone1E, I, RYes?
(8)32ML hand tenosynovitisNoneLocal steroid injection1E, R, sulfamethoxazoleYes24
(8)42ML hand tenosynovitisShrimp fishingNone3E, I, RYes24
(8)52FR hand tenosynovitisShrimp spine injuryNone1D, E, RNo24
(8)31FL index finger tenosynovitisCrab biteLocal steroid injection6D, E, RYes24
(9)56ML index finger osteomyelitis and wrist synovitisFishermanLocal steroid injections12E, M, RYes9
(10)5MPolyarthritis, disseminated skin lesions, hepatic function abnormalitiesNoneAbnormalities in monocyte function48A, clofazamine, E, R, TNo9
(11)35FL hand and wrist septic arthritis, cutaenous lesions on armPuffer fish stingSystemic steroids for SLE flares18MNo>12
(12)62FL middle finger osteomyelitis with skin nodulesInjury while gardening, owned tropical fish aquariumNone8E, RYes4
(13)33MR hand nodules, LAD, pneumonia, bacteremiaFish tankAIDS (CD4<5)0.5C, clofazimine, ethionamideYes3 until death
(14)56ML ring finger septic arthritis, osteomyelitisMinor trauma, fish tankLocal steroid injection2C, E, RNo12
(15)0.25MDiffuse pustules, osteomyelitis, bacteremiaBathed in bathtub in which fishtank washedSCID?I, R, TNo6 until death
(16)71MR 2nd MCP synovitis, septic arthritis, osteomyelitisSwimming and fishing injuryLocal steroid injection9C, E, I, RYes12
(17)48FL hand osteomyelitis, R forearm cutaneous lesions, R ankle septic arthritis and osteomyelitisFish tank cleaningCyclosphosphamide and systemic steroids for polymyositis10D, I pyrazinamide, RYes5
(18)52FR hand tenosynovitis and osteomyelitisFish dealer, puncture injurySystemic steroids and local herbal injections2Clarithromycin, D, E, I, RYes18
(19)41FR index flexor sheath tenosynovitisFishmongerLocal steroid injection3MYes1.5
(20)53MR middle finger tenosynovitis, septic arthritis, wrist osteomyelitis, discharging sinusesNonpenetrating trauma, home aquariumLocal steroid injections, systemic methotrexate24C, E, R, SNo13
(21)81ML forearm plaque, L index finger ulcer, R forearm cellulitis, bone marro cx + pancytopeniaAquarium exposureSystemic steroids and azathioprine for myasthenia gravis5C, DNo<1 before death
(22)22MR wrist tenosynovitis, nodular skin lesions“Fish-related hobby”, aquariumSystemic steroids for Still’s disease0.25C, clarithromycin, E, RYes4
(23)70MR hand and wrist tenosynovitis, subcutaneous nodules, L knee septic arthritisFish fin woundSystemic steroids12A, E, M, RYes12
(24)60FDisseminated ulcerating abscessesTropical aquariumSystemic steroids and chemotherapy for non-Hodgkin lymphoma8clarithromycin, clotrimazole, E, immunoglobulins, levofloxacin, R, S,No?

aDx, diagnosis; l, left; R, right; MCP,metacarpophalangeal; A, amikacin; C, ciprofloxacin; D, doxycycline; E, ethambutol; I, isoniazid; M, minocycline; P, pyrazinamide; R, rifampin; S, streptomycin; T, trimethoprim/sulfamethoxazole

aDx, diagnosis; l, left; R, right; MCP,metacarpophalangeal; A, amikacin; C, ciprofloxacin; D, doxycycline; E, ethambutol; I, isoniazid; M, minocycline; P, pyrazinamide; R, rifampin; S, streptomycin; T, trimethoprim/sulfamethoxazole Most cases occurred in previously healthy adults. The average age was 43 years; 24 (69%) were men; 21 (60%) had tenosynovitis; 6 (17%) had septic arthritis; and 13 (37%) had osteomyelitis. In three patients (9%), either a bone marrow or blood culture positive for M. marinum was obtained; all three patients showed marked systemic immunocompromise. Multiple skin lesions were seen in 23% of cases; half of these patients showed clear evidence of deeper infection. Some patients had more than one manifestation of invasive disease. Immunologic impairment was a frequent component of invasive M. marinum infections: 14 (40%) of case-patients received a steroid injection at the site of infection, and 9 (26%) were receiving systemic steroids for various indications. An additional 4 (11%) case-patients were in an immunocompromised state from other sources such as chemotherapy or AIDS. Delayed diagnosis was also a prominent finding: The average time to diagnosis was 17 months from symptom onset. The treatment course was prolonged and aggressive: The average treatment duration was 11.4 months in the 20 reports in which a definitive duration was given. Surgery was undertaken in 69% of the cases. The treatment regimen used varied considerably, although 30 (88%) of the 34 patients who took antimycobacterial medications received combination therapy. Rifampin (76%) and ethambutol (68%) were the predominant agents. While M.yocobacterium marinum infections usually arise from aquatic trauma in healthy hosts, delayed diagnosis and immune suppression contribute to the pathogenesis of invasive infection. Tenosynovitis is the most common manifestation of deep invasion, although septic arthritis and osteomyelitis are well described. Disseminated skin lesions can accompany deeper invasion but may be seen in isolation as well. Bone marrow invasion and bacteremia are rare and have been seen only in profoundly immunocompromised patients. Although the rarity of the condition makes estimating its incidence difficult, the number of case reports per year has remained stable for the last 30 years. However, the high frequency of delayed diagnosis in cases of invasive M. marinum disease underscores the importance of maintaining a high level of suspicion for this condition, especially in patients who have evidence of previous aquatic trauma or refractory soft tissue infections. Further, since immunosupression was common in cases of invasive disease, local steroid injections should be avoided in patients with soft tissue infection after aquatic trauma at least until M. marinum infection is ruled out by acid-fast staining or mycobacterial culture of biopsy specimens or fluids. Once invasive M. marinum disease was diagnosed, patients with invasive disease were treated for an average of 11.4 months, three times longer than the typical course for M. marinum superficial infections (). Rifampin and ethambutol were used most often in invasive infections, although many therapeutic choices exist. In a study of 61 clinical isolates, rifamycins and clarithromycin were the most potent, with the lowest MICs, and resistance was uncommon. Doxycycline, ethambutol, and minocycline all showed higher MICs but were still effective (). A different group tested 11 agents against 37 clinical isolates and found that trimethoprim/sulfamethoxazole was the most potent agent, but 92% of isolates were susceptible. Clarithromycin and minocycline, by contrast, showed susceptibility rates approaching 100% and retained similar potency (). This study reported an MIC50 for most quinolones of 4 μg/mL or higher, although in a different study, 100% of M. marinum isolates were susceptible to gatifloxacin (). Approximately three fourths of isolates in this latter study were susceptible to ciprofloxacin and levofloxacin. Among newer antibiotics tested against M. marinum in this series, only linezolid showed much promise (). On the basis of the sparse data correlating susceptibility testing results to clinical response, and the relative infrequency of resistance, recent guidelines suggest foregoing susceptibility testing in M. marinum infections unless the infection does not respond to treatment (). Most cases of invasive M. marinum infection require surgical debridement, 69% in this series. This approach seems particularly appropriate in immunocompromised patients, those with tenosynovitis, or those for whom medical therapy fails.
  27 in total

1.  A case of disseminated Mycobacterium marinum infection following systemic steroid therapy.

Authors:  P L Ho; P Ho; B K Fung; W Y Ip; S S Wong
Journal:  Scand J Infect Dis       Date:  2001

2.  An unusual case of flexor sheath tenosynovitis.

Authors:  R Gatt; P Cushieri; C Sciberras
Journal:  J Hand Surg Br       Date:  1998-10

3.  Mycobacterium marinum flexor tenosynovitis.

Authors:  J N Lacy; S F Viegas; J Calhoun; J T Mader
Journal:  Clin Orthop Relat Res       Date:  1989-01       Impact factor: 4.176

4.  Mycobacterium marinum (atypical acid-fast bacillus) infections of the hand.

Authors:  C S Williams; D C Riordan
Journal:  J Bone Joint Surg Am       Date:  1973-07       Impact factor: 5.284

5.  Mycobacterium marinum (balnei) infection. Report of a case with cutaneous and laryngeal lesions.

Authors:  W M Gould; D R McMeekin; R D Bright
Journal:  Arch Dermatol       Date:  1968-02

Review 6.  Mycobacterium marinum arthritis.

Authors:  J A Alloway; S M Evangelisti; J S Sartin
Journal:  Semin Arthritis Rheum       Date:  1995-06       Impact factor: 5.532

7.  Osteomyelitis and synovitis produced by Mycobacterium marinum in a fisherman.

Authors:  R B Clark; H Spector; D M Friedman; K J Oldrati; C L Young; S C Nelson
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

8.  Osteomyelitis and tenosynovitis due to Mycobacterium marinum in a fish dealer.

Authors:  J Y Shih; P R Hsueh; Y L Chang; M T Chen; P C Yang; K T Luh
Journal:  J Formos Med Assoc       Date:  1997-11       Impact factor: 3.282

9.  Susceptibility testing for mycobacteria.

Authors:  G L Woods
Journal:  Clin Infect Dis       Date:  2000-11-06       Impact factor: 9.079

Review 10.  Septic arthritis due to Mycobacterium marinum.

Authors:  M Harth; E D Ralph; R Faraawi
Journal:  J Rheumatol       Date:  1994-05       Impact factor: 4.666

View more
  10 in total

1.  Atypical Mycobacterial Infections of the Upper Extremity: Becoming More Atypical?

Authors:  Mariela Lopez; Julie Croley; Kevin D Murphy
Journal:  Hand (N Y)       Date:  2016-07-07

Review 2.  The fauna and perspective of rodentia ectoparasites in Iran relying on their roles within public health and veterinary characteristics.

Authors:  Mousa Khosravani
Journal:  J Parasit Dis       Date:  2017-10-03

3.  Genetic diversity and population structure of Mycobacterium marinum: new insights into host and environmental specificities.

Authors:  Vincent Broutin; Anne-Laure Bañuls; Alexandra Aubry; Nicolas Keck; Marc Choisy; Jean-François Bernardet; Christian Michel; Jean-Christophe Raymond; Cédric Libert; Antoine Barnaud; Pieter Stragier; Françoise Portaels; Dominique Terru; Claudine Belon; Olivier Dereure; Cristina Gutierrez; Maria-Laura Boschiroli; Philippe Van De Perre; Emmanuelle Cambau; Sylvain Godreuil
Journal:  J Clin Microbiol       Date:  2012-09-05       Impact factor: 5.948

4.  "You never asked doc., I do fish".

Authors:  Fawad Aslam; Bernard Ng
Journal:  Clin Rheumatol       Date:  2009-09-01       Impact factor: 2.980

5.  Disseminated Mycobacterium marinum in Human Immunodeficiency Virus Unmasked by Immune Reconstitution Inflammatory Syndrome.

Authors:  Maura Manion; Augusto Dulanto Chiang; Luxin Pei; Chun-Shu Wong; Pavel Khil; Dima A Hammoud; Megan Anderson; Elizabeth Laidlaw; Safia Kuriakose; Andrea Lisco; Adrian M Zelazny; John P Dekker; Irini Sereti
Journal:  J Infect Dis       Date:  2021-08-02       Impact factor: 5.226

Review 6.  Mycobacterium marinum: ubiquitous agent of waterborne granulomatous skin infections.

Authors:  B Petrini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-10       Impact factor: 5.103

7.  Necrotizing Soft Tissue Infection Occurring after Exposure to Mycobacterium marinum.

Authors:  Shivani S Patel; M Lance Tavana; M Sean Boger; Soe Soe Win; Bassam H Rimawi
Journal:  Case Rep Infect Dis       Date:  2014-11-19

8.  Disseminated Mycobacterium marinum Infection With a Destructive Nasal Lesion Mimicking Extranodal NK/T Cell Lymphoma: A Case Report.

Authors:  Takanori Asakura; Makoto Ishii; Taku Kikuchi; Kaori Kameyama; Ho Namkoong; Noboru Nakata; Kayoko Sugita; Sadatomo Tasaka; Takayuki Shimizu; Yoshihiko Hoshino; Shinichiro Okamoto; Tomoko Betsuyaku; Naoki Hasegawa
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

9.  Evaluation of the SLOMYCO Sensititre(®) panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates.

Authors:  Marion Chazel; Hélène Marchandin; Nicolas Keck; Dominique Terru; Christian Carrière; Michael Ponsoda; Véronique Jacomo; Gilles Panteix; Nicolas Bouzinbi; Anne-Laure Bañuls; Marc Choisy; Jérôme Solassol; Alexandra Aubry; Sylvain Godreuil
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-05-06       Impact factor: 3.944

10.  Mycobacterium marinum Tenosynovitis following Steroid Injection in an Avid Seaman from Long Island, New York.

Authors:  Eric Sin; George Psevdos; Luis A Marcos
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.